Francis Esteban Matos: Final Debarment Order
FDA issued a final debarment order against Francis Esteban Matos, prohibiting him from importing or offering for import any drug for 5 years. This affects any pharmacy or entity that relies on Matos for drug importation.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 24, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Pharmacies and drug importers that have business relationships with Francis Esteban Matos or entities he controls. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately upon publication (July 24, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Francis Esteban Matos is now debarred from importing drugs into the U.S. for 5 years.
Who it affects
Pharmacies and drug importers that have business relationships with Francis Esteban Matos or entities he controls.
What you must do
Cease any import activities involving Matos and review supply chains to ensure no drugs are sourced through him.
Deadline
Immediately upon publication (July 24, 2026).
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- US-CONGRESS S5043: Secure Drug Supply Chain Act of 2026
- Ohio Board of Pharmacy Proposes Strengthened Disciplinary Actions: What Pharmacies Need to Know - Buchanan Ingersoll & Rooney PC
- Nevada’s Proposed New Regulations: What Pharmacies Need to Know - Buchanan Ingersoll & Rooney PC
- US-CONGRESS BILLS-119hr9599ih: Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act; SECURE 340B Act
- US-CONGRESS BILLS-119hr9790ih: Modernizing Opioid Treatment Access Act 2.0 of 2026